nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—ABCB1—Lisinopril—systemic scleroderma	0.216	0.272	CbGbCtD
Mebendazole—ABCB1—Captopril—systemic scleroderma	0.162	0.203	CbGbCtD
Mebendazole—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.127	0.16	CbGbCtD
Mebendazole—ABCB1—Prednisone—systemic scleroderma	0.102	0.128	CbGbCtD
Mebendazole—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0763	0.0959	CbGbCtD
Mebendazole—CYP3A4—Prednisone—systemic scleroderma	0.061	0.0767	CbGbCtD
Mebendazole—ABCB1—Methotrexate—systemic scleroderma	0.0511	0.0642	CbGbCtD
Mebendazole—TUBA1A—connective tissue—systemic scleroderma	0.00543	0.103	CbGeAlD
Mebendazole—TUBA1A—smooth muscle tissue—systemic scleroderma	0.00497	0.0942	CbGeAlD
Mebendazole—TUBA1A—skin of body—systemic scleroderma	0.0049	0.093	CbGeAlD
Mebendazole—Hepatitis—Pentoxifylline—systemic scleroderma	0.00442	0.0291	CcSEcCtD
Mebendazole—TUBA1A—digestive system—systemic scleroderma	0.00392	0.0744	CbGeAlD
Mebendazole—Neutropenia—Captopril—systemic scleroderma	0.00391	0.0257	CcSEcCtD
Mebendazole—TUBA1A—tendon—systemic scleroderma	0.00373	0.0708	CbGeAlD
Mebendazole—TUBB4B—connective tissue—systemic scleroderma	0.00362	0.0686	CbGeAlD
Mebendazole—Angioedema—Pentoxifylline—systemic scleroderma	0.00352	0.0231	CcSEcCtD
Mebendazole—Agranulocytosis—Captopril—systemic scleroderma	0.00348	0.0229	CcSEcCtD
Mebendazole—Hepatitis—Captopril—systemic scleroderma	0.00335	0.022	CcSEcCtD
Mebendazole—Convulsion—Pentoxifylline—systemic scleroderma	0.00333	0.0219	CcSEcCtD
Mebendazole—TUBB4B—smooth muscle tissue—systemic scleroderma	0.00331	0.0628	CbGeAlD
Mebendazole—TUBA1A—lung—systemic scleroderma	0.00328	0.0621	CbGeAlD
Mebendazole—TUBB4B—skin of body—systemic scleroderma	0.00327	0.062	CbGeAlD
Mebendazole—Neutropenia—Leflunomide—systemic scleroderma	0.00323	0.0212	CcSEcCtD
Mebendazole—Neutropenia—Mycophenolic acid—systemic scleroderma	0.00308	0.0202	CcSEcCtD
Mebendazole—Agranulocytosis—Azathioprine—systemic scleroderma	0.00304	0.02	CcSEcCtD
Mebendazole—Angioedema—Mometasone—systemic scleroderma	0.00303	0.02	CcSEcCtD
Mebendazole—Agranulocytosis—Leflunomide—systemic scleroderma	0.00287	0.0189	CcSEcCtD
Mebendazole—Neutropenia—Lisinopril—systemic scleroderma	0.00277	0.0182	CcSEcCtD
Mebendazole—Hepatitis—Leflunomide—systemic scleroderma	0.00276	0.0182	CcSEcCtD
Mebendazole—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00274	0.018	CcSEcCtD
Mebendazole—Angioedema—Captopril—systemic scleroderma	0.00266	0.0175	CcSEcCtD
Mebendazole—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00263	0.0173	CcSEcCtD
Mebendazole—TUBB4B—digestive system—systemic scleroderma	0.00261	0.0496	CbGeAlD
Mebendazole—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00257	0.0169	CcSEcCtD
Mebendazole—Urticaria—Pentoxifylline—systemic scleroderma	0.00249	0.0164	CcSEcCtD
Mebendazole—TUBB4B—tendon—systemic scleroderma	0.00249	0.0472	CbGeAlD
Mebendazole—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00248	0.0163	CcSEcCtD
Mebendazole—Agranulocytosis—Lisinopril—systemic scleroderma	0.00247	0.0162	CcSEcCtD
Mebendazole—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.00243	0.016	CcSEcCtD
Mebendazole—Hepatitis—Lisinopril—systemic scleroderma	0.00237	0.0156	CcSEcCtD
Mebendazole—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00231	0.0152	CcSEcCtD
Mebendazole—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00222	0.0146	CcSEcCtD
Mebendazole—Angioedema—Leflunomide—systemic scleroderma	0.0022	0.0144	CcSEcCtD
Mebendazole—TUBB4B—lung—systemic scleroderma	0.00218	0.0414	CbGeAlD
Mebendazole—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00216	0.0142	CcSEcCtD
Mebendazole—Abdominal pain—Mometasone—systemic scleroderma	0.00214	0.0141	CcSEcCtD
Mebendazole—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00208	0.0137	CcSEcCtD
Mebendazole—ABCB1—blood vessel—systemic scleroderma	0.00205	0.0389	CbGeAlD
Mebendazole—Convulsion—Mycophenolic acid—systemic scleroderma	0.00199	0.0131	CcSEcCtD
Mebendazole—Rash—Pentoxifylline—systemic scleroderma	0.00198	0.013	CcSEcCtD
Mebendazole—Dermatitis—Pentoxifylline—systemic scleroderma	0.00198	0.013	CcSEcCtD
Mebendazole—Gastrointestinal pain—Captopril—systemic scleroderma	0.00195	0.0128	CcSEcCtD
Mebendazole—Angioedema—Lisinopril—systemic scleroderma	0.00189	0.0124	CcSEcCtD
Mebendazole—Abdominal pain—Captopril—systemic scleroderma	0.00188	0.0124	CcSEcCtD
Mebendazole—CYP1A1—skin of body—systemic scleroderma	0.00183	0.0347	CbGeAlD
Mebendazole—Rash—Mometasone—systemic scleroderma	0.00171	0.0112	CcSEcCtD
Mebendazole—Dermatitis—Mometasone—systemic scleroderma	0.00171	0.0112	CcSEcCtD
Mebendazole—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.0017	0.0112	CcSEcCtD
Mebendazole—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00165	0.0109	CcSEcCtD
Mebendazole—Neutropenia—Prednisone—systemic scleroderma	0.00165	0.0108	CcSEcCtD
Mebendazole—Abdominal pain—Azathioprine—systemic scleroderma	0.00164	0.0108	CcSEcCtD
Mebendazole—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.0016	0.0106	CcSEcCtD
Mebendazole—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00157	0.0103	CcSEcCtD
Mebendazole—Urticaria—Leflunomide—systemic scleroderma	0.00156	0.0102	CcSEcCtD
Mebendazole—Abdominal pain—Leflunomide—systemic scleroderma	0.00155	0.0102	CcSEcCtD
Mebendazole—Hypersensitivity—Azathioprine—systemic scleroderma	0.00153	0.0101	CcSEcCtD
Mebendazole—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00153	0.0101	CcSEcCtD
Mebendazole—Rash—Captopril—systemic scleroderma	0.0015	0.00987	CcSEcCtD
Mebendazole—Dermatitis—Captopril—systemic scleroderma	0.0015	0.00986	CcSEcCtD
Mebendazole—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00148	0.00973	CcSEcCtD
Mebendazole—CYP1A1—digestive system—systemic scleroderma	0.00146	0.0278	CbGeAlD
Mebendazole—Hypersensitivity—Leflunomide—systemic scleroderma	0.00145	0.00951	CcSEcCtD
Mebendazole—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00138	0.00907	CcSEcCtD
Mebendazole—Neutropenia—Methotrexate—systemic scleroderma	0.00138	0.00905	CcSEcCtD
Mebendazole—Urticaria—Lisinopril—systemic scleroderma	0.00134	0.00881	CcSEcCtD
Mebendazole—Abdominal pain—Lisinopril—systemic scleroderma	0.00133	0.00876	CcSEcCtD
Mebendazole—Rash—Azathioprine—systemic scleroderma	0.00131	0.00861	CcSEcCtD
Mebendazole—Dermatitis—Azathioprine—systemic scleroderma	0.00131	0.00861	CcSEcCtD
Mebendazole—Hypersensitivity—Lisinopril—systemic scleroderma	0.00124	0.00817	CcSEcCtD
Mebendazole—Rash—Leflunomide—systemic scleroderma	0.00124	0.00814	CcSEcCtD
Mebendazole—Dermatitis—Leflunomide—systemic scleroderma	0.00124	0.00813	CcSEcCtD
Mebendazole—Agranulocytosis—Methotrexate—systemic scleroderma	0.00122	0.00805	CcSEcCtD
Mebendazole—CYP1A1—lung—systemic scleroderma	0.00122	0.0232	CbGeAlD
Mebendazole—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00794	CcSEcCtD
Mebendazole—Rash—Mycophenolic acid—systemic scleroderma	0.00118	0.00776	CcSEcCtD
Mebendazole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00118	0.00775	CcSEcCtD
Mebendazole—Hepatitis—Methotrexate—systemic scleroderma	0.00118	0.00775	CcSEcCtD
Mebendazole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00772	CcSEcCtD
Mebendazole—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00768	CcSEcCtD
Mebendazole—Angioedema—Prednisone—systemic scleroderma	0.00112	0.00737	CcSEcCtD
Mebendazole—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00716	CcSEcCtD
Mebendazole—CYP3A4—digestive system—systemic scleroderma	0.00107	0.0204	CbGeAlD
Mebendazole—Rash—Lisinopril—systemic scleroderma	0.00106	0.00699	CcSEcCtD
Mebendazole—Convulsion—Prednisone—systemic scleroderma	0.00106	0.00699	CcSEcCtD
Mebendazole—Dermatitis—Lisinopril—systemic scleroderma	0.00106	0.00698	CcSEcCtD
Mebendazole—Rash—Mycophenolate mofetil—systemic scleroderma	0.000931	0.00612	CcSEcCtD
Mebendazole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00093	0.00612	CcSEcCtD
Mebendazole—Convulsion—Methotrexate—systemic scleroderma	0.000888	0.00584	CcSEcCtD
Mebendazole—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000819	0.00538	CcSEcCtD
Mebendazole—Urticaria—Prednisone—systemic scleroderma	0.000795	0.00523	CcSEcCtD
Mebendazole—Abdominal pain—Prednisone—systemic scleroderma	0.000791	0.00521	CcSEcCtD
Mebendazole—ABCB1—digestive system—systemic scleroderma	0.00076	0.0144	CbGeAlD
Mebendazole—Hypersensitivity—Prednisone—systemic scleroderma	0.000738	0.00485	CcSEcCtD
Mebendazole—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000684	0.0045	CcSEcCtD
Mebendazole—Urticaria—Methotrexate—systemic scleroderma	0.000665	0.00437	CcSEcCtD
Mebendazole—Abdominal pain—Methotrexate—systemic scleroderma	0.000661	0.00435	CcSEcCtD
Mebendazole—ABCB1—lung—systemic scleroderma	0.000635	0.012	CbGeAlD
Mebendazole—Rash—Prednisone—systemic scleroderma	0.000631	0.00415	CcSEcCtD
Mebendazole—Dermatitis—Prednisone—systemic scleroderma	0.000631	0.00415	CcSEcCtD
Mebendazole—Hypersensitivity—Methotrexate—systemic scleroderma	0.000616	0.00405	CcSEcCtD
Mebendazole—Rash—Methotrexate—systemic scleroderma	0.000528	0.00347	CcSEcCtD
Mebendazole—Dermatitis—Methotrexate—systemic scleroderma	0.000527	0.00347	CcSEcCtD
